Zhao Yongdong, Dedeoglu Fatma, Ferguson Polly J, Lapidus Sivia K, Laxer Ronald M, Bradford Miranda C, Li Suzanne C
Pediatric Rheumatology, Seattle Children's Hospital, Seattle, WA, USA.
Rheumatology, Boston Children's Hospital, Boston, MA, USA.
Int J Rheumatol. 2017;2017:7694942. doi: 10.1155/2017/7694942. Epub 2017 Jan 10.
. Understanding the practices of pediatric rheumatologists in diagnosing and treating chronic nonbacterial osteomyelitis (CNO) can provide important information to guide the development of consensus treatment plans. The objectives of this study were to determine physicians' approaches to (1) diagnosing and monitoring CNO, (2) ordering a bone biopsy, and (3) making treatment decisions. . A survey was distributed among members of the Childhood Arthritis and Rheumatology Research Alliance using a web-based questionnaire. . 121 of 277 (41%) attending physician members completed the survey. Plain radiographs (89%) were most commonly used followed by regional MRI (78%), bone scintigraphy (43%), and whole-body MRI (36%). The top three reasons for performing a biopsy were constitutional findings (66%), unifocal bone lesions (64%), and nocturnal bone pain (45%). Nearly all responders (95%) prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) as initial therapy. For patients who failed NSAID treatment, methotrexate (67%), tumor necrosis factor inhibitors (65%), and bisphosphonates (46%) were the next most commonly used treatments. The presence of a spinal lesion increased the use of bisphosphonate treatment. . The diagnostic approach and disease activity monitoring for CNO varied among surveyed physicians. Our survey findings provided important background for the development of consensus treatment plans for CNO.
了解儿科风湿病学家在诊断和治疗慢性非细菌性骨髓炎(CNO)方面的实践,可以为制定共识治疗方案提供重要信息。本研究的目的是确定医生在(1)诊断和监测CNO、(2)安排骨活检以及(3)做出治疗决策方面的方法。通过基于网络的问卷对儿童关节炎和风湿病研究联盟的成员进行了调查。277名主治医师成员中有121名(41%)完成了调查。最常用的检查是X线平片(89%),其次是局部MRI(78%)、骨闪烁显像(43%)和全身MRI(36%)。进行活检的三大原因是全身症状(66%)、单灶性骨病变(64%)和夜间骨痛(45%)。几乎所有受访者(95%)都将非甾体抗炎药(NSAIDs)作为初始治疗药物。对于NSAID治疗失败的患者,甲氨蝶呤(67%)、肿瘤坏死因子抑制剂(65%)和双膦酸盐(46%)是接下来最常用的治疗方法。脊柱病变的存在增加了双膦酸盐治疗的使用。参与调查的医生在CNO的诊断方法和疾病活动监测方面存在差异。我们的调查结果为制定CNO的共识治疗方案提供了重要背景。